A bill to require manufacturers of drugs to post the names of the countries in which their drugs are manufactured on their internet websites.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senator for Missouri. Democrat.
Last Updated: Jun 21, 2018
Length: 2 pages
Jun 21, 2018
115th Congress, 2017–2019
Died in a previous Congress
This bill was introduced on June 21, 2018, in a previous session of Congress, but was not enacted.
Jun 21, 2018
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
S. 3105 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). S. 3105 — 115th Congress: Pharmaceutical Origin Transparency Act of 2018. Retrieved from https://www.govtrack.us/congress/bills/115/s3105
“S. 3105 — 115th Congress: Pharmaceutical Origin Transparency Act of 2018.” www.GovTrack.us. 2018. May 23, 2019 <https://www.govtrack.us/congress/bills/115/s3105>
Pharmaceutical Origin Transparency Act of 2018, S. 3105, 115th Cong..
|title=S. 3105 (115th)
|accessdate=May 23, 2019
|author=115th Congress (2018)
|date=June 21, 2018
|quote=Pharmaceutical Origin Transparency Act of 2018
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.